Search Results 21-30 of 8603 for Raloxifene
Raloxifene (oral route) · Raltegravir (oral route) · Ramelteon (oral route) · Ramipril (oral route) · Ramucirumab (intravenous route). RAN-Fenofibrate S. Also ...
Blocking estrogen helps stop cancer from forming. Hormone-blocking medicines that are used to lower breast cancer risk include: Tamoxifen; Raloxifene (Evista) ...
... raloxifene, a Mayo Clinic-led study has found. Mayo Clinic oncologist, James Ingle, M.D., says, “Our findings are important, because we identified genetic ...
Relugolix, estradiol, and norethindrone combination is used to manage heavy menstrual bleeding caused by uterine leiomyomas (fibroids) in premenopausal women.
Raloxifene (Evista). Anastrozole (Arimidex). Exemestane (Aromasin). These medicines are typically taken daily for five years to reduce the risk of breast ...
Because COVID-19 infection is associated with an increased risk of hypercoagulable complications, we did exercise caution in patients on estrogen and raloxifene ...
Therapy with any hormonal agent such as raloxifene for management of osteoporosis. Patients are eligible only if these medications are discontinued prior to ...
This phase II pilot trial studies how well bicalutamide and raloxifene hydrochloride work in treating patients with prostate cancer undergoing surgery.
Relugolix is used in men to treat advanced prostate cancer. Relugolix is a type of medicine called a gonadotropin-releasing hormone (GnRH) antagonist. It helps ...
However, neither tamoxifen nor raloxifene appear to reduce fracture incidence in postmenopausal women with breast cancer. Aromatase inhibitors decrease ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.